Table 1.

mRECIST

Category	mRECIST Criteria Description
CR	All target lesion enhancements are visible during the arterial phase and have completely disappeared.
PR	The sum of the diameters of the target lesion enhancements during the arterial phase and has decreased by ≥ 30%.
SD	The sum of the diameters of the target lesion enhancements during the arterial phase has decreased but not reached PR, or has increased but not reached PD.
PD	The sum of the diameters of the target lesion enhancements during the arterial phase has increased by ≥ 20% or new lesions have appeared.

Note: mRECIST, Modified Response Evaluation Criteria in Solid Tumors; CR, Complete Response; PR, Partial Response; SD, Stable Disease; PD, Progressive Disease.